FDA approves Winrevair for pulmonary arterial hypertension in adults
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
Treatment for infants who have severe pulmonary arterial hypertension (PAH) is sometimes limited. Because they haven't physically matured, a procedure could increase the risk of serious complications, including failure of ...
Feb 22, 2024
0
0
Environmental epidemiologists at Columbia University Mailman School of Public Health, in collaboration with an interdisciplinary team of researchers at Oregon State University, Pacific Northwest National Labs, and Mt. Sinai ...
Jan 10, 2024
0
1
A team from Peking Union Medical College Hospital in Beijing, China, have explored changes in the characteristics, treatment, and 5-year survival for SLE-associated PAH in the last decade, and possible reasons for survival ...
Jun 2, 2023
0
2
The amount of environmental exposure to polycyclic aromatic hydrocarbons, or PAH for short, is strongly linked to a person's risk of developing rheumatoid arthritis, suggests research published in the open access journal ...
May 9, 2023
1
80
Patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs, who were treated with the novel first-in-class medication sotatercept on top of existing therapy experienced ...
Mar 7, 2023
0
193
Patients with pulmonary arterial hypertension (high blood pressure in the arteries that supply the lungs, also called PAH) had approximately double the reduction in pulmonary vascular resistance (PVR) if they took the PAH ...
Mar 7, 2023
0
1
Pulmonary arterial hypertension (PAH) is a rare and incurable disease of the lung arteries that causes early death. In PAH, excess scar tissue and thickening of lung blood vessels occur as the result of increased cell "biomass." ...
Jan 20, 2023
0
10
Treatments for pulmonary arterial hypertension (PAH)—a type of high blood pressure that affects arteries in the lungs and in the heart—have improved significantly over the past 15 to 20 years and researchers at the University ...
Oct 17, 2022
0
15
You may be surprised to learn that the medication sildenafil—better known by its brand name Viagra—has other medical purposes aside from treating male erectile dysfunction. It can also be used to treat lung diseases that ...
Sep 29, 2022
0
9